Level Four Advisory Services’s Tandem Diabetes Care TNDM Stock Holding History

Level Four Advisory Services’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,267	Closed	-$253K	–	587
2022 Q2	$253K	Sell	4,267 -2,891	-40%	-$237K	0.02%	477
2022 Q1	$832K	Buy	7,158 +5,293	+284%	+$618K	0.07%	280
2021 Q4	$281K	Buy	+1,865	New	+$252K	0.02%	519

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Level Four Advisory Services's TNDM Position: Q3 2022 in Review

Level Four Advisory Services sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 4,267 shares — an estimated $253K sold.

Level Four Advisory Services first reported a position in TNDM in Q4 2021 and held it in 3 quarters. The position peaked at $832K in Q1 2022. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

Level Four Advisory Services reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
Level Four Advisory Services sold 4,267 Tandem Diabetes Care shares in Q3 2022, an estimated $253K.
Level Four Advisory Services first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 3 quarters.
Level Four Advisory Services's Tandem Diabetes Care position peaked at $832K in Q1 2022.
299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Level Four Advisory Services's 13F filing for Q3 2022, filed 7 Nov 2022.